Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer
Liyuan Peng, Jingwen Jiang, Hai‐Ning Chen, et al.
Cell Reports (2021) Vol. 37, Iss. 9, pp. 110069-110069
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 129
Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo, Li Zhou, Zhao Huang, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1128-1128
Open Access | Times Cited: 114
Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
Li Yang, Xiaoyue Zhang, Zhihan Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 34
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 27
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 10
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection
Weidong Zhang, Chao Wu, Hanchen Huang, et al.
Translational Oncology (2025) Vol. 52, pp. 102238-102238
Closed Access | Times Cited: 1
Recent advances in Surface-Enhanced Raman Scattering (SERS) for the diagnosis, treatment, and prognosis of ovarian cancer
Biqing Chen, Xiaohong Qiu, Yang Li
Microchemical Journal (2025), pp. 112787-112787
Closed Access | Times Cited: 1
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
Jang Mi Han, Hye Jin Jung
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9341-9341
Open Access | Times Cited: 35
PPIH acts as a potential predictive biomarker for patients with common solid tumors
Jun Ye, Jianchao Ying, Hạixia Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts
Xinjie Chen, Guoyu Cheng, Liang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101576-101576
Open Access | Times Cited: 6
A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer
Hui Ming, Bowen Li, Hailong Tian, et al.
Materials Today Bio (2022) Vol. 15, pp. 100289-100289
Open Access | Times Cited: 27
Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy
Siyuan Qin, Bowen Li, Hui Ming, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188749-188749
Open Access | Times Cited: 23
The Role of Peroxiredoxins in Cancer Development
Pratik Thapa, Hong Jiang, Na Ding, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 666-666
Open Access | Times Cited: 16
NQO1 Triggers Neutrophil Recruitment and NET formation to Drive Lung Metastasis of Invasive Breast Cancer
Xinzhi Wang, Yi Qu, Qianqian Xu, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3538-3555
Closed Access | Times Cited: 5
Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
Ali H. El‐Far, Soad K. Al Jaouni, Xiaotao Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3181-3201
Closed Access | Times Cited: 20
Peptide release, radical scavenging capacity, and antioxidant responses in intestinal cells are determined by soybean variety and gastrointestinal digestion under simulated conditions
Miguel Rebollo‐Hernanz, Jennifer Kusumah, Neal A. Bringe, et al.
Food Chemistry (2022) Vol. 405, pp. 134929-134929
Open Access | Times Cited: 20
Targeting Metabolic–Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy
Yuke Wang, Jingqiu He, Shan Lian, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 828-828
Open Access | Times Cited: 4
Cyclophilin A: promising target in cancer therapy
Shujuan Jin, Mengjiao Zhang, Xiaoting Qiao
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
An injectable hydrogel for synergistic therapy in colorectal cancer by targeting glutathione
Jingqiu Zhou, Dongyu Jia, Lei Jin, et al.
Cell Reports Physical Science (2025), pp. 102399-102399
Open Access
Genetically encoding ε-N-methacryllysine into proteins in live cells
Tianyi Zhu, Shi‐Yi Chen, Mengdi Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Promoting activities of human cyclophilin A on calcium oxalate stone formation at crystal growth, aggregation and crystal-cell adhesion phases
Sudarat Hadpech, Waralee Srinarawat, Visith Thongboonkerd
International Journal of Biological Macromolecules (2025), pp. 143374-143374
Open Access
Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest
Jinyu Shi, Li Zhou, Hui-Si Huang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3747-3761
Open Access | Times Cited: 16
Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy
Lei Li, Ping Jin, Yueyue Guan, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1540-1540
Open Access | Times Cited: 15
Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review)
Chi-Yun Shao, Yanjie Han, Yuying Huang, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 2
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top